Sonoma Pharmaceuticals (SNOA) Change in Acquisitions & Divestments (2015)

Sonoma Pharmaceuticals' (SNOA) quarterly Change in Acquisitions & Divestments came in at $4.5 million in Q2 2015.

Sonoma Pharmaceuticals (SNOA) Change in Acquisitions & Divestments (2015) Analysis & Trends

Sonoma Pharmaceuticals' Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $4.5 million for Q2 2015.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $4.5 million in Q2 2015; TTM through Mar 2016 was $4.5 million, a N/A change from a year earlier, with the FY2016 full-year figure at $4.5 million, up 371.24% from the prior year.
  • Change in Acquisitions & Divestments steadied at $4.5 million in Q2 2015 per SNOA's latest filing.
  • Across five years, Change in Acquisitions & Divestments topped out at $4.5 million in Q2 2015 and bottomed at $4.5 million in Q2 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.51 Bn 87.64 Bn -
2 Teva Pharmaceutical Industries 35.95 Bn 32.21 Bn 1.97 Bn
3 Zoetis 32.59 Bn 30.65 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.51 Bn 23.45 Bn 4.39 Bn
5 United Therapeutics 23.06 Bn 20.91 Bn 648.10 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn -
7 Viatris 20.25 Bn 18.44 Bn 1.16 Bn
8 Neurocrine Biosciences 17.79 Bn 16.48 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Sonoma Pharmaceuticals 1.97 Mn -428,888.50 2.18 Mn

Historic Data

Download Data
DateValue
Jun 30, 2015 4.54 Mn
Jun 30, 2015 4.54 Mn